GEORGE E. TAFFET, MD
Osteopathic Medicine at Main St, Houston, TX
License number
Texas H1536
Category
Osteopathic Medicine
Type
Geriatric Medicine
Address
Address
6620 Main St, Houston, TX 77030
Phone
(713) 798-2500
(713) 798-2505 (Fax)
(713) 798-2505 (Fax)
Personal information
See more information about GEORGE E. TAFFET at radaris.comName
Address
Phone
4131 Turnberry Cir, Houston, TX 77025
Houston, TX
4059 Aberdeen Ct, Houston, TX 77025
4131 Turnberry Cir, Houston, TX 77025
Organization information
See more information about GEORGE E. TAFFET at bizstanding.comGeorge E Taffet MD
4131 Turnberry Cir, Houston, TX 77025
Industry:
Business Consulting
Phone:
(713) 798-5804 (Phone)
Medical Doctor, Owner:
George E. Taffet (Medical Doctor, Owner)
Categories:
Business Services
Professional information
See more information about GEORGE E. TAFFET at trustoria.com
Dr. George E Taffet, Houston TX - MD (Doctor of Medicine)
Dr. George E Taffet, Houston TX - MD (Doctor of Medicine)
Specialties:
Geriatric Medicine
Address:
Baylor Geriatrics Senior Care Clinic at Park Plaza
1200 Binz St SUITE 710, Houston 77004
(713) 285-1730 (Phone), (713) 285-1740 (Fax)
Baylor Clinic Geriatrics
1200 Binz St SUITE 710, Houston 77004
(713) 798-3967 (Phone)
6620 Flr SUITE 12TH, Houston 77030
1200 Binz St SUITE 710, Houston 77004
(713) 285-1730 (Phone), (713) 285-1740 (Fax)
Baylor Clinic Geriatrics
1200 Binz St SUITE 710, Houston 77004
(713) 798-3967 (Phone)
6620 Flr SUITE 12TH, Houston 77030
Certifications:
Geriatric Medicine, Internal Medicine
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Baylor Geriatrics Senior Care Clinic at Park Plaza
1200 Binz St SUITE 710, Houston 77004
Baylor Clinic Geriatrics
1200 Binz St SUITE 710, Houston 77004
6620 Flr SUITE 12TH, Houston 77030
Ben Taub General Hospital
1504 Taub Loop, Houston 77030
Park Plaza Hospital
1313 Hermann Dr, Houston 77004
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
The Methodist Hospital
6565 Fannin St, Houston 77030
1200 Binz St SUITE 710, Houston 77004
Baylor Clinic Geriatrics
1200 Binz St SUITE 710, Houston 77004
6620 Flr SUITE 12TH, Houston 77030
Ben Taub General Hospital
1504 Taub Loop, Houston 77030
Park Plaza Hospital
1313 Hermann Dr, Houston 77004
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
The Methodist Hospital
6565 Fannin St, Houston 77030
Education:
Medical School
Brown Medical School
Graduated: 1982
Baylor Coll Med Affil Hosp
Graduated: 1983
Baylor College Of Medicine Geriatrics Fellowship
Graduated: 1988
Brown Univ
Graduated: 1979
Brown Medical School
Graduated: 1982
Baylor Coll Med Affil Hosp
Graduated: 1983
Baylor College Of Medicine Geriatrics Fellowship
Graduated: 1988
Brown Univ
Graduated: 1979
George Efrem Taffet, Houston TX
George Efrem Taffet, Houston TX
Specialties:
Internal Medicine, Geriatric Medicine, General Practice
Work:
St Luke's Episcopal Hospital
1709 Dryden Rd, Houston, TX 77030 Baylor College of Medicine
6620 Main St, Houston, TX 77030 Baylor College of Medicine
1200 Binz St, Houston, TX 77004
1709 Dryden Rd, Houston, TX 77030 Baylor College of Medicine
6620 Main St, Houston, TX 77030 Baylor College of Medicine
1200 Binz St, Houston, TX 77004
Education:
Brown University (1982)
Protease Resistant Ti-Growth Hormone Releasing Hormone
Protease Resistant Ti-Growth Hormone Releasing Hormone
US Patent:
2004019, Sep 30, 2004
Filed:
Aug 21, 2002
Appl. No.:
10/166356
Inventors:
Ruxandra Draghia-Akli - Houston TX, US
Marta Fiorotto - Houston TX, US
George Taffet - Houston TX, US
Marta Fiorotto - Houston TX, US
George Taffet - Houston TX, US
Assignee:
Baylor College of Medicine - Houston TX
International Classification:
A61K038/17
US Classification:
514/012000
Abstract:
One aspect of the current invention is a composition for a modified growth hormone releasing hormone (“GHRH”) or functional biological equivalent thereof. Another aspect of the current invention includes a nucleic acid molecule that encodes the modified GHRH or functional biological equivalent. The modified GHRH can be defined as a biologically active polypeptide that was engineered to contain a distinct amino acid sequence while simultaneously having similar or improved biologically activity when compared to a wild-type GHRH (“wt-GHRH”) polypeptide. Another aspect of the current invention includes a method for delivering the composition of this invention to a subject, wherein the modified GHRH increases the level of growth hormone (“GH”) secretion in a subject. The preferred subject is a human or domesticated animal. Additionally, the modified GHRH composition is resistant to degradation when compared to the wt-GHRH.